Tepotinib efficacy and safety in patients with MET exon 14 (METex14) skipping NSCLC Meeting Abstract


Authors: Garassino, M. C.; Le, X.; Iam, W. T.; Felip, E.; Sakai, H.; Veillon, R.; Smit, E. F.; Mazieres, J.; Raskin, J.; Cortot, A. B.; Berghoff, K.; Bruns, R.; Otto, G.; Paik, P. K.
Abstract Title: Tepotinib efficacy and safety in patients with MET exon 14 (METex14) skipping NSCLC
Meeting Title: 113th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 82
Issue: 12 Suppl.
Meeting Dates: 2022 Apr 8-13
Meeting Location: New Orleans, LA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2022-06-15
Language: English
ACCESSION: WOS:000892509500059
PROVIDER: wos
DOI: 10.1158/1538-7445.AM2022-CT536
Notes: Meeting Abstract: CT536 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik